Latest from Healthcare

Quality of life: Acacia Pharma is developing products aimed at supportive care

British medical company Acacia Pharma secures £15 million funding

A Series B venture capital financing round worth £15 million has been led by Fidelity Biosciences and Novo A/S.

New approach: There is no need for fridges or freezers with Biofortuna technology

Biofortuna secures more venture capital cash to ramp up US efforts

Molecular diagnostics business Biofortuna has closed another round of venture capital funding so that it can target the US market.

High street: Chemists in the UK are growing revenues by adding new products

Private equity looks to pharmacy market for solid returns through consolidation

The steady income streams and low risk profiles of pharmacy businesses are proving increasingly attractive for private equity investors, new figures suggest.

Practice Plan will be adding to Wesleyan Assurance Society's dental offering

Practice Plan finds new home with trade buyer after Dunedin Private Equity exit

An eight-year involvement with dental membership plan business Practice Plan has netted Dunedin Private Equity a 2.8x return on its investment.

Olympian: Sir Chris Hoy is an official brand ambassador for Sport in Science

Sports nutrition business used by Sir Chris Hoy joins London's junior exchange

Science in Sport is targeting its share of a reported £19.6 billion global market in 2010 by securing a stock market listing.

Willowbrook Healthcare now employs 938 staff and has 13 freehold homes

Graphite Capital closes third healthcare exit with same management team

Private equity firm Graphite Capital has followed up on its recent investment in the Hawksmoor chain of restaurants by exiting its interest in Willowbrook Healthcare.

The Biomedical Catalyst was designed to target the 'valley of death' funding gap

Spending review outlines raft of new healthcare sector business investments

The Biomedical Catalyst is allocating £25.9 million as part of a new support package for businesses and academic projects in the health industry.

Clinical research: The inventor of the SnapFast£ system, Ryan Cawood

'Lego for DNA' biotech start-up secures £150,000 of SEIS capital from Mercia

The Seed Enterprise Investment Scheme (SEIS) has allowed biotechnology business Oxford Genetics to net £150,000 of new funding.

Biomedical market: Absynth is developing vaccines to treat bacterial infections

Spin-out biomedical business gets SPARK Impact-led investment

The North West Fund for Biomedical and Fusion IP are coming together to back the growth ambition of University of Sheffield spin-out Absynth Biologics.

Medical market: Tomorrows Medicines operates in the clinical trials sector

The North West Fund for Biomedical makes 60th investment

A £250,000 investment led North West Fund for Biomedical will be used by Tomorrows Medicines to commercialise its new platform.

Software service: CliniSys produces products for clinical laboratories

ECI Partners sells CliniSys to Montagu Equity Partners to close first exit of 2013

Private equity firm ECI Partners has sold its stake in CliniSys and netted a 2.5x return on its 2007 investment.

Lower costs: ChemistDirect has taken the pharmacy online

Online pharmacy set up in garden shed dials up $10 million Atomico-led investment

Venture capital firm Atomico has stepped up to lead a $10 million investment into ChemistDirect.

Innovation: Imperial invests in tech from four universities, including Cambridge

Imperial Innovations pulls in £30 million from EIB to invest in biotech

AIM-listed investment firm Imperial Innovations Group has secured a £30 million loan so that it can make investments in the biotech and therapeutics sectors.

Sitting pretty: Beverly Lawrence was marketing director before becoming MD

NVM Private Equity backs second MBO in a week

A thirty one-year old specialist furniture business has taken on private equity backing as it looks to grow through organic and acquisitive means.

Healthcare work: Perfecus Biomed conducts microbiological testing on bacteria

Perfectus Biomed signs up two venture capital backers for infection treatment development

The £25 million North West Fund for Biomedical has made its 57th investment to date through the backing of Perfectus Biomed.

Breakthrough: Index Ventures believes the new drug could save millions of lives

Index Ventures closes its biggest life sciences investment in heart attack prevention drug

An $11 million investment from Index Ventures will be used to develop an anticoagulant drug aimed at preventing heart attacks and strokes without causing bleeding.

Medical sector: Fishawack is on its second private equity backer

Fishawack acquisition takes 12-month deal count to seven for Growth Capital Partners

Growth Capital Partners portfolio company Fishawack has completed its first acquisition since the private equity firm backed a secondary buy-out at the company back in March.

Corporate care: The incubator will be based at the Alliance Boots Beeston base

Wellness and health start-up incubator launched by Alliance Boots

A new collaboration between Alliance Boots and BioCity will see the creation of a new business incubator focused on health and wellness.

Institutional backing: TrialReach has now closed two funding rounds in two years

TrialReach adds Octopus Investments to list of investors through £2 million venture capital deal

Octopus Investments has led a £2 million investment into clinical trials platform TrialReach alongside Amadeus Capital Partners.

Medical innovation: Cerus Endovascular is tackling intracranial aneurysms

Oxford-based medical technology firm secures investment from The North West Fund for Biomedical

Cerus Endovascular is moving its operations to Liverpool Science Park following backing from The North West Fund for Biomedical.

More from GrowthBusiness

The Entrepreneur

Jamie Turner drew a number of conclusions from Tech Entrepreneur Week

Key learnings from Tech Entrepreneur Week

Jamie Turner, CTO at Postcode Anywhere, examines Tech Entrepreneur Week to determine what must be done to build a great technology company.

Growing A Business

With savings not offering much return, there are growing options elsewhere

Working out which of peer-to-peer lending or equity crowdfunding is best for investors

For investors looking for good returns, picking what type of alternative finance to engage with is an important decision.

Comment & Analysis

Getting involved with the International Festival for Business

Taking Tech Invest north in search of businesses hoping to grow through equity funding.


What moves small-cap share prices?

Research report into the top-performing 100 companies below the FTSE 350 and on AIM.